Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Piro

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Clinical Investigation|November 1, 1990
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapyC J Carrera, C Terai, M Lotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
2-Chlorodeoxyadenosine treatment of low-grade lymphomasA C Kay, A Saven, C J Carrera, et al.
Blood|December 15, 1994
Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemiaD J Ellison, R W Sharpe, B A Robbins, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive NucleosideE Beutler, L D Piro, A Saven, et al.
Blood|August 15, 1993
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemiaB A Robbins, D J Ellison, J C Spinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancyA Saven, W K Cheung, I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
2-Chlorodeoxyadenosine dose escalation in nonhematologic malignanciesA Saven, H Kawasaki, C J Carrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignanciesB R Meisenberg, W E Miller, R McMillan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphomaL D Piro, C A White, A J Grillo-López, et al.
Blood|May 15, 1997
Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodesS Krajewski, R D Gascoyne, J M Zapata, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Clinical Investigation|November 1, 1990
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapyC J Carrera, C Terai, M Lotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
2-Chlorodeoxyadenosine treatment of low-grade lymphomasA C Kay, A Saven, C J Carrera, et al.
Blood|December 15, 1994
Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemiaD J Ellison, R W Sharpe, B A Robbins, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive NucleosideE Beutler, L D Piro, A Saven, et al.
Blood|August 15, 1993
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemiaB A Robbins, D J Ellison, J C Spinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancyA Saven, W K Cheung, I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
2-Chlorodeoxyadenosine dose escalation in nonhematologic malignanciesA Saven, H Kawasaki, C J Carrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignanciesB R Meisenberg, W E Miller, R McMillan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphomaL D Piro, C A White, A J Grillo-López, et al.
Blood|May 15, 1997
Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodesS Krajewski, R D Gascoyne, J M Zapata, et al.
Pageof 5